Evidence map›Paper›PMID 26339354›Full record

ArticleInternational journal of clinical and experimental pathology2015

Glutamine ameliorates intestinal ischemia-reperfusion Injury in rats by activating the Nrf2/Are signaling pathway.

Ai-Li Wang, Qiong Niu, Ning Shi, Jian Wang, Xing-Fang Jia, Hai-Feng Lian, Zhiqiang Liu, Cheng-Xia Liu

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Oxidative medicine and cellular longevity · 2022
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ai-Li WangDepartment of Gastroenterology, Binzhou Medical College Affiliated Hospital Binzhou, China.
Qiong NiuDepartment of Gastroenterology, Binzhou Medical College Affiliated Hospital Binzhou, China.
Ning ShiDepartment of Gastroenterology, Binzhou Medical College Affiliated Hospital Binzhou, China.
Jian WangDepartment of Gastroenterology, Binzhou Medical College Affiliated Hospital Binzhou, China.
Xing-Fang JiaDepartment of Gastroenterology, Binzhou Medical College Affiliated Hospital Binzhou, China.
Hai-Feng LianDepartment of Gastroenterology, Binzhou Medical College Affiliated Hospital Binzhou, China.
Zhiqiang LiuCenter for Cancer Immunology Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
Cheng-Xia LiuDepartment of Gastroenterology, Binzhou Medical College Affiliated Hospital Binzhou, China.
Binzhou Medical University · CNThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia-reperfusion (I/R)-mediated intestinal mucosal injury is usually induced by oxygen-derived toxic free radicals from the xanthine oxidase system after reperfusion, but the detailed molecular mechanisms underlying glutamine protection is still unclear. This study aims to elucidate whether glutamine prevents damage to the intestinal mucosa after I/R in rats and to investigate signaling by the Nrf2/ARE pathway induced by GLN in a rat model. Our results revealed that Glutamine pretreatment reduced jejunum injury and microvascular hyper-permeability induced by I/R. MDA level significantly increased while the SOD and GSH-Px levels decreased in the I/R group compared to the sham group and the GLN-I/R group. Both the mRNA and protein levels of the Nrf2 and HO-1 were significantly elevated by GLN pretreatment when compared to the I/R group. GLN treatment also elevated Bcl-2 levels, and accordingly suppressed apoptotic damage in the jejunum cells shown by decreased cleaved caspase-3 level. Mechanistic investigation revealed that GLN treatment augmented binding of Nrf2 onto Bcl2 gene promoter. These results indicate that glutamine has protective effects on I/R in vivo by activating the Nrf2/ARE signaling pathway to inhibit ROS production and reduce intestinal apoptosis.

Indexed as

Antioxidant Response ElementsGlutamineJejunal DiseasesJejunumNF-E2-Related Factor 2Reperfusion InjurySignal TransductionAnimalsBinding SitesCaspase 3CytoprotectionDisease Models, AnimalGene Expression RegulationGlutathione PeroxidaseHeme Oxygenase (Decyclizing)MaleCasp3 protein, ratCaspase 3GlutamineGlutathione PeroxidaseHeme Oxygenase (Decyclizing)Hmox1 protein, ratMalondialdehydeNfe2l2 protein, ratNF-E2-Related Factor 2Proto-Oncogene Proteins c-bcl-2Superoxide DismutaseBcl2Glutamineintestinal ischemia-reperfusion injuryNrf2/ARE signaling pathway

Identifiers

PMID26339354
PMCPMC4555682
OpenAlexW2417583153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.